IL6 and neoplasm: Immunohistochemistry staining demonstrated lower numbers of positive-stained IL-6, STAT3 and HIF1 cells in tumor tissues developed from siRNA-IL-6 knockdown cells, as compared with that of the CSC-derived xenografts.